Regulation & law · 14/08/2023Updated: 10/17/2026 · 1 min read
Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Review of Proposed Transaction
Summary
The Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which is expected to close in the second half of 2023
Original source language: Federal Register — Justice DepartmentOpen original release →